D'Alessandro Anthony M, Fernandez Luis A, Chin L Thomas, Shames Brian D, Turgeon Nicole A, Scott David L, Di Carlo Antonio, Becker Yolanda T, Odorico Jon S, Knechtle Stuart J, Love Robert B, Pirsch John D, Becker Bryan N, Musat Alexandru I, Kalayoglu Munci, Sollinger Hans W
Department of Surgery, University of Wisconsin Medical School, USA.
Ann Transplant. 2004;9(1):68-71.
The objective of this analysis was to compare the results of transplantation of livers, pancreases, kidneys, and lungs from donation after cardiac death (DCD) donors to organs transplanted from donation after brain death (DBD) donors.
From January 1984 through July 2000, outcomes of 382 DCD kidneys were compared to 1,089 kidneys (SPK) transplants and 36 liver transplants from DCD donors were compared to 455 SPK and 510 liver transplants from DBD donors. Likewise, 31 simultaneous pancreas-kidneys transplants from DBD donors.
The rate of delayed graft function (DGF) was higher in kidneys transplanted from DCD donors (27.5% versus 21.3%, p=0.01). Likewise, discharge creatinines were higher in recipients of DCD kidneys (1.9 mg/dL versus 1.7 mg/dL, p=0.001). There was no difference in 10-year graft survival between DCD and DBD recipients (45.0% versus 48.0%, p=0.054). No difference in 5-year pancreatic and renal allograft survival was seen after SPK from DCD or DBD donors. After liver transplantation, biliary strictures were higher in recipients of DCD livers (13.9% versus 8.0%, p=0.03). Likewise, 3-year patient and graft survivals were lower for recipients of DCD livers (65.8% versus 84.9%, p=0.01; and 58.6% versus 76.9%, p=0.006).
This large experience with transplantation from DCD donors demonstrates that similar patient and graft survivals can be expected when compared to recipients of organs from DBD donors.
本分析的目的是比较心脏死亡后捐赠(DCD)供体的肝脏、胰腺、肾脏和肺移植结果与脑死亡后捐赠(DBD)供体的器官移植结果。
从1984年1月至2000年7月,将382例DCD肾脏的移植结果与1089例肾脏(SPK)移植结果进行比较,并将36例DCD供体的肝脏移植结果与455例SPK和510例DBD供体的肝脏移植结果进行比较。同样,对31例DBD供体的同期胰肾联合移植进行了比较。
DCD供体移植的肾脏延迟移植功能(DGF)发生率更高(27.5%对21.3%,p=0.01)。同样,DCD肾脏受者的出院时肌酐水平更高(1.9mg/dL对1.7mg/dL,p=0.001)。DCD和DBD受者的10年移植肾存活率无差异(45.0%对48.0%,p=0.054)。DCD或DBD供体的SPK术后5年胰腺和肾移植存活率无差异。肝移植后,DCD肝脏受者的胆道狭窄发生率更高(13.9%对8.0%,p=0.03)。同样,DCD肝脏受者的3年患者和移植存活率较低(65.8%对84.9%,p=0.01;58.6%对76.9%,p=0.006)。
这项关于DCD供体移植的大量经验表明,与DBD供体器官的受者相比,可以预期类似的患者和移植存活率。